SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John H. Farro who wrote (542)9/27/1996 12:06:00 PM
From: Rick Costantino   of 4342
 
I was just checking out the Paracelsian web site. I have a few
comments.

It is a good start, but they really need to expand it some.
For example, include info on their factilities, employees, patents,
and so on. I also noted that it needs updating as it states that
"Phase I trials of PN355,1 will being in January 1996. This trial
is already completed (we wawait release of the data). Also, I noted
they mentioned PN355,1 was starting Phase I in late 1996. I'm not
aware of an IND filing for this...this move will certainly help out
the stock.

One new thing I did read was that PN27,1 was shown effective against
resentosis. This could be a huge market. Are they pursuing this
at all? Anyone hear anything?

Patiently waiting,

Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext